These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19540307)

  • 21. Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat.
    Lima N; Cavaliere H; Knobel M; Halpern A; Medeiros-Neto G
    Int J Obes Relat Metab Disord; 2000 Nov; 24(11):1433-7. PubMed ID: 11126339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for hypogonadism in massively obese males due to decreased free testosterone.
    Kley HK; Deselaers T; Peerenboom H
    Horm Metab Res; 1981 Nov; 13(11):639-41. PubMed ID: 7198085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells?
    Winters SJ; Wang C; Abdelrahaman E; Hadeed V; Dyky MA; Brufsky A
    J Androl; 2006; 27(4):560-4. PubMed ID: 16582411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of leptin to insulin resistance syndrome in children.
    Steinberger J; Steffen L; Jacobs DR; Moran A; Hong CP; Sinaiko AR
    Obes Res; 2003 Sep; 11(9):1124-30. PubMed ID: 12972683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypogonadism in male patients with cancer.
    Garcia JM; Li H; Mann D; Epner D; Hayes TG; Marcelli M; Cunningham GR
    Cancer; 2006 Jun; 106(12):2583-91. PubMed ID: 16688773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study.
    Camacho EM; Huhtaniemi IT; O'Neill TW; Finn JD; Pye SR; Lee DM; Tajar A; Bartfai G; Boonen S; Casanueva FF; Forti G; Giwercman A; Han TS; Kula K; Keevil B; Lean ME; Pendleton N; Punab M; Vanderschueren D; Wu FC;
    Eur J Endocrinol; 2013 Mar; 168(3):445-55. PubMed ID: 23425925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypogonadotropic hypogonadism in men with type 2 diabetes.
    Dandona P; Dhindsa S; Chandel A; Chaudhuri A
    Postgrad Med; 2009 May; 121(3):45-51. PubMed ID: 19491539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metabolic effects of obesity in men].
    Vermeulen A
    Verh K Acad Geneeskd Belg; 1993; 55(5):383-93; discussion 393-7. PubMed ID: 8128779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea.
    Tkacova R; Dorkova Z; Molcanyiova A; Radikova Z; Klimes I; Tkac I
    Med Sci Monit; 2008 Sep; 14(9):CR438-44. PubMed ID: 18758413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypogonadotrophic hypogonadism in type 2 diabetes.
    Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
    Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome.
    Gravholt CH; Jensen AS; Høst C; Bojesen A
    Acta Paediatr; 2011 Jun; 100(6):871-7. PubMed ID: 21342256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The beneficial effects of toremifene administration on the hypothalamic-pituitary-testicular axis and sperm parameters in men with idiopathic oligozoospermia.
    Farmakiotis D; Farmakis C; Rousso D; Kourtis A; Katsikis I; Panidis D
    Fertil Steril; 2007 Oct; 88(4):847-53. PubMed ID: 17412336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease.
    Guarner-Lans V; Rubio-Ruiz ME; Pérez-Torres I; Baños de MacCarthy G
    Exp Gerontol; 2011 Jul; 46(7):517-23. PubMed ID: 21397002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight.
    Calderón B; Gómez-Martín JM; Vega-Piñero B; Martín-Hidalgo A; Galindo J; Luque-Ramírez M; Escobar-Morreale HF; Botella-Carretero JI
    Andrology; 2016 Jan; 4(1):62-7. PubMed ID: 26663756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ageing of the hypothalamo-pituitary-testicular axis in men.
    Vermeulen A; Kaufman JM
    Horm Res; 1995; 43(1-3):25-8. PubMed ID: 7721258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of obesity on health outcomes.
    Dixon JB
    Mol Cell Endocrinol; 2010 Mar; 316(2):104-8. PubMed ID: 19628019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of obesity on the male reproductive axis.
    Mihalca R; Fica S
    J Med Life; 2014 Jun; 7(2):296-300. PubMed ID: 25408743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deleterious effects of obesity upon the hormonal and molecular mechanisms controlling spermatogenesis and male fertility.
    Davidson LM; Millar K; Jones C; Fatum M; Coward K
    Hum Fertil (Camb); 2015 Sep; 18(3):184-93. PubMed ID: 26205254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment.
    Hofstra J; Loves S; van Wageningen B; Ruinemans-Koerts J; Jansen I; de Boer H
    Neth J Med; 2008 Mar; 66(3):103-9. PubMed ID: 18349465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.